Skip to main content
CourtGPT logoCourtGPT
Directory
Law
For Attorneys
Blog
AppointmentsSign InSign Up
Section 18-506 - Statewide Steering Committee on Services for Adults With Sickle Cell Disease — Maryland Law | CourtGPT
  1. Home/
  2. Laws/
  3. Maryland/
  4. Health General/
  5. Title 18 - Disease Prevention/
  6. Subtitle 5 - Sickle Cell Anemia/
  7. Section 18-506 - Statewide Steering Committee on Services for Adults With Sickle Cell Disease
Maryland Legal Code

Section 18-506 - Statewide Steering Committee on Services for Adults With Sickle Cell Disease

Ask AI about this
(a) In this section, 'Steering Committee' means the Statewide Steering Committee on Sickle Cell Disease. (b) There is a Statewide Steering Committee on Sickle Cell Disease. (c) The Steering Committee shall include representatives from: (1) Local and national groups that advocate for individuals with sickle cell disease; (2) Interest and support groups for individuals with sickle cell disease; (3) Community and consumer groups; (4) Academic and private clinical settings with knowledge and experience caring for adults with sickle cell disease; (5) Area hospitals caring for individuals with sickle cell disease; and (6) Pediatric clinics that care for children with sickle cell disease. (d) The Steering Committee shall: (1) Establish institution and community partnerships; (2) Establish a statewide network of stakeholders who care for individuals with sickle cell disease; (3) Educate individuals with sickle cell disease, the public, and health care providers about the State options for care of sickle cell disease; and (4) Identify funding sources for implementing or supporting the actions, studies, policies, regulations, or laws recommended by the Steering Committee, including funding

e of sickle cell disease; and (4) Identify funding sources for implementing or supporting the actions, studies, policies, regulations, or laws recommended by the Steering Committee, including funding from: (i) State, federal, and local government sources; and (ii) Private sources.